Nuzenio

Tradingview Carlsmed

Tradingview Carlsmed entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 9 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Carlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside - TradingViewTradingView · Thu, 06 Aug 2026 07:20:06 GMTCarlsmed, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 00:01:00 GMTCARLSMED, INC. Q2 2026: Revenue $18.94M, EPS $(0.39) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMTCarlsmed Q2 revenue rises 57%, raises 2026 revenue forecast - TradingViewTradingView · Wed, 05 Aug 2026 20:15:55 GMTCarlsmed reports Q2 2026 revenue $18.9M, raises full-year guidance to $74–$78M - TradingViewTradingView · Wed, 05 Aug 2026 20:13:03 GMTCARL: Q2 revenue up 57% year-over-year; full-year guidance raised on strong demand and CMS changes - TradingViewTradingView · Wed, 05 Aug 2026 20:09:50 GMTCARL Stock Price and Chart — NASDAQ:CARL - TradingViewTradingView · Wed, 05 Aug 2026 07:00:00 GMTEnterprise value to EBITDA forward of Carlsmed, Inc. – NASDAQ:CARL - TradingViewTradingView · Sat, 01 Aug 2026 06:29:16 GMT

Timeline

Thu, 06 Aug 2026 07:20:06 GMTCarlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside - TradingView
Thu, 06 Aug 2026 00:01:00 GMTCarlsmed, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 20:26:35 GMTCARLSMED, INC. Q2 2026: Revenue $18.94M, EPS $(0.39) — 10-Q Summary - TradingView
Wed, 05 Aug 2026 20:15:55 GMTCarlsmed Q2 revenue rises 57%, raises 2026 revenue forecast - TradingView
Wed, 05 Aug 2026 20:13:03 GMTCarlsmed reports Q2 2026 revenue $18.9M, raises full-year guidance to $74–$78M - TradingView
Wed, 05 Aug 2026 20:09:50 GMTCARL: Q2 revenue up 57% year-over-year; full-year guidance raised on strong demand and CMS changes - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Carlsmed.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.